News

Filter by news category

  • Filter by business unit / brand

  • 4th February 2025

    DIH Expands Strategic Partnership with Zahrawi Group

    DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), today announced the expansion of their strategic partnership with Zahrawi Group (MTC Company), DIH's representative and sales partner, to include Saudi Arabia.

    MORE
    4th February 2025

    DIH Announces Closing of $4.6 Million Public Offering

    DIH Holding US, Inc., today announced the closing of its previously announced public offering of an aggregate of 5,937,100 units at a public offering price of $0.7832 per unit.

    MORE
    28th January 2025

    DIH Announces Strategic Partnership with Nobis Rehabilitation Partners

    DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), today announced its new partnership with Nobis Rehabilitation Partners. This collaboration signifies an important advancement as Nobis plans to integrate Andago®, an overground gait and balance training device, into every one of their newly established hospitals.

    MORE
    23rd December 2024

    DIH Appoints Shepherd Center as a DIH Center of Excellence

    DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI) today announced the appointment of Shepherd Center as DIH Center of Excellence. Through this partnership, DIH and Shepherd Center aim to further enhance rehabilitation outcomes and drive advancements in rehabilitation, creating new opportunities for patient recovery.

    MORE
    16th December 2024

    DIH Appoints Sheltering Arms Institute as a DIH Center of Excellence

    DIH Holding US, Inc. (NASDAQ: DHAI) today announced the designation of Sheltering Arms Institute, a collaboration with VCU Health, as DIH Center of Excellence. By partnering with Sheltering Arms Institute, DIH continues to build a strong presence among top-tier healthcare providers dedicated to enhancing patient recovery journeys through innovation-driven care solutions.

    MORE
    15th November 2024

    DIH Announces Second Quarter 2025 Financial Results and Restates June 30, 2024 Form 10-Q

    DIH Holding US, Inc. (NASDAQ: DHAI) announced a 39% year-over-year revenue increase in Q2 2025, reaching $18.2M, driven by 49% growth in device revenue. The EMEA region led with a 72% increase, and gross margin improved to 52.6%. Fiscal 2025 revenue guidance is updated to $60M–$67M.

    MORE
    5th November 2024

    DIH Appoints Dietmar Dold as Chief Operating Officer

    Mr. Dold brings to DIH over 25 years of operating experience across multiple industries, and has demonstrated significant expertise in driving innovative transformation on a global scale.

    MORE
    26th September 2024

    DIH Announces Formation and Inaugural Meeting of Scientific Advisory Board

    The newly formed SAB will advise DIH on technical and scientific pursuits, offer insights into the latest trends in the scientific and clinical communities, provide feedback on product development, and advise DIH on research plans and projects.

    MORE
    30th August 2024

    DIH Appoints Haapsalu Neurological Rehabilitation Center as a DIH Center of Excellence

    DIH Holding US, Inc. has named Haapsalu Neurological Rehabilitation Center in Estonia as its latest Center of Excellence. HNRC, known for its pioneering work in neurological rehabilitation, is the first in the Baltics to receive this recognition.

    MORE
    26th June 2024

    Zihlschlacht Rehabilitation Clinic Appointed as the First DIH Center of Excellence in Switzerland

    The Zihlschlacht Rehabilitation Clinic, established in 1891 as a sanatorium, has been appointed the first DIH Center of Excellence in Switzerland. Located in an idyllic location on the Swiss side of Lake Constance, the clinic is renowned for its leadership in treating neurological diseases and its pioneering efforts in neurorehabilitation and research.

    MORE
    Load more
    X